Biotech
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 01/13/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and de ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 01/13/12 -- (NASDAQ: BASI) announced today it will make a presentation at the Noble Financial Capital Markets Eighth Annual Equity Conference, Wednesday, Janua ...
DENVER, CO: DENVER, CO -- (Marketwire) -- 01/13/12 -- (OTCBB: OMBP), a clinical-stage biopharmaceutical company, today announced its intention to commence new human clinical trials to test the efficacy of Alpha- ...
SOUTH SAN FRANCISCO, CA: Oral Factor Xa Inhibitor Betrixaban to Start Phase 3 Trial; Oral Syk-Specific Kinase Inhibitor to Start Phase 2 Trial; Novel Recombinant Factor Xa Inhibitor Antidote to Start Phase 1 Trial; Portola in ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 01/12/12 -- Warnex Inc. (TSX: WNX) ("Warnex" or the "Company") announces that the Toronto Stock Exchange ("TSX") has determined, furthe ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/12/12 -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) announced today that it will be co ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 01/11/12 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed a private offe ...
BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 01/11/12 -- (NASDAQ: CBLI) today announced that the Company is scheduled to present at Noble Financial Capital Markets' Eighth Annual Equity Conference, BOCEMb 20 ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 01/11/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Professor Rudy Tanzi has been appointed as Chief Scientific Advisor to the Comp ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/11/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") is pleased to announce the appointment of Mr. Kito Tosetti, a se ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/10/12 -- Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX VENTURE: PGA) announced today that all resolutio ...
BOULDER, CO: BOULDER, CO -- (Marketwire) -- 01/10/12 -- MBio Diagnostics, Inc. announced that its CEO, Christopher Myatt, Ph.D., will present at the BioTech Showcase 2012 in San Francisco on January 11th at 9:00 ...
BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 01/10/12 -- Cerecor Inc today announced that Sol J. Barer, Ph.D., a current board member, has been elected the Chairman of Cerecor's Board of Directors, effecti ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 01/10/12 -- Novo Energies Corporation ("Novo") (OTCBB: NVNC) today announced that it is in the process of taking the steps necessary to effect a name change ...
BOTHELL, WA: Through Partnership and Licensing Agreements, Marina Biotech's Drug Discovery Platform Brought in Over $1.5 MM in Non-Dilutive Capital in the Fourth Quarter of 2011 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/09/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") announced it has appointed Mr. Christopher Morris as interim Chi ...
DENVER, CO: DENVER, CO -- (Marketwire) -- 01/09/12 -- (OTCBB: OMBP), a clinical-stage biopharmaceutical company, today announced that it will present at Noble Financial Capital Markets' Eighth Annual Equi ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 01/09/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that the Company will meet with several prospective licensing partners inc ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/09/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") is pleased to announce it has retained the services of Momentum ...
